Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
Bordignon MB, Pesce Viglietti AI, Juliá EP, Sanchez MB, Rölle A, Mandó P, Sabatini L, Ostinelli A, Rizzo MM, Barrio MM, Mordoh J, Fainboim L, Levy EM. Bordignon MB, et al. Among authors: sanchez mb. Cancer Immunol Immunother. 2023 Aug;72(8):2687-2700. doi: 10.1007/s00262-023-03448-w. Epub 2023 Apr 21. Cancer Immunol Immunother. 2023. PMID: 37081323 Free PMC article.
Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia.
Ruiz MS, Sanchez MB, Gutiérrez L, Koile D, Yankilevich P, Mosqueira C, Cranco S, Custidiano MDR, Freitas J, Foncuberta C, Moiraghi B, Pavlovsky C, Pérez MA, Ventriglia V, Ávalos JS, Mordoh J, Larripa I, Bianchini M. Ruiz MS, et al. Among authors: sanchez mb. Oncotarget. 2018 Apr 17;9(29):20255-20264. doi: 10.18632/oncotarget.24749. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755649 Free PMC article.
miRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.
Ruiz MS, Sánchez MB, Bonecker S, Furtado C, Koile D, Yankilevich P, Cranco S, Custidiano MDR, Freitas J, Moiraghi B, Pérez MA, Pavlovsky C, Varela AI, Ventriglia V, Sánchez Ávalos JC, Larripa I, Zalcberg I, Mordoh J, Valent P, Bianchini M. Ruiz MS, et al. Among authors: sanchez avalos jc, sanchez mb. Front Pharmacol. 2021 Jan 11;11:612573. doi: 10.3389/fphar.2020.612573. eCollection 2020. Front Pharmacol. 2021. PMID: 33569005 Free PMC article.
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Pavlovsky C, Vasconcelos Cordoba B, Sanchez MB, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, de Labanca AG, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Cueto G, Miranda S, Levy EM, Bianchini M. Pavlovsky C, et al. Among authors: sanchez mb. J Hematol Oncol. 2023 Apr 29;16(1):43. doi: 10.1186/s13045-023-01440-6. J Hematol Oncol. 2023. PMID: 37120577 Free PMC article.
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Sanchez MB, Vasconcelos Cordoba B, Pavlovsky C, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, García de Labanca A, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Levy EM, Bianchini M. Sanchez MB, et al. Front Immunol. 2023 Sep 25;14:1241600. doi: 10.3389/fimmu.2023.1241600. eCollection 2023. Front Immunol. 2023. PMID: 37818372 Free PMC article. Clinical Trial.
Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
Ruiz MS, Sánchez MB, Vera Contreras YM, Agrielo E, Alonso M, Altuna ME, Anchordoqui MS, Asinari M, Bonetto ME, Camargo M, Giere I, González J, Granda Alacote AC, Guerra J, Gutiérrez M, Maldonado C, Makiya R, Manrique G, Monaco ME, Rozo JC, Santamaría C, Seravalle A, Zea O, Zubillaga MN, Mordoh J, Larripa I, Bianchini M. Ruiz MS, et al. Among authors: sanchez mb. Clin Chem Lab Med. 2020 Nov 26;58(12):2025-2035. doi: 10.1515/cclm-2019-1283. Clin Chem Lab Med. 2020. PMID: 32374276
Prevalence of digestive manifestations in patients with amyloidosis.
Sánchez MB, Dolores Matoso M, Aguirre MA, Mercedes Nucifora E, Marciano S, Cepeda J, Rinaudo S, Binder F, Lourdes Posadas Martinez M, Rafael Boietti B, Marcolongo M. Sánchez MB, et al. Amyloid. 2019;26(sup1):103-104. doi: 10.1080/13506129.2019.1582492. Amyloid. 2019. PMID: 31343360 No abstract available.
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
Villarroel PG, Padró JG, Marquina G, Jáñez NM, González EE, Antón A, Sánchez MB, Cáceres AR, López-López R, Cornejo RE, García PB, Fabregat RM, Fernández BC, Bermudo CL, Camps C. Villarroel PG, et al. Among authors: sanchez mb. Future Oncol. 2022 Nov;18(35):3913-3927. doi: 10.2217/fon-2022-0758. Epub 2022 Dec 20. Future Oncol. 2022. PMID: 36537885 Free article.
88 results